Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Giant Biogene Holding CoHKSE:02367 +0.50%85 Days Payable is 89.01 as of Dec. 2025, which is 68% above its 10-year median of 53.06. GuruFocus rates HKSE:02367 with a GF Score™ of 85/100 and a GF Value™ of HK$68.00 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,909 Consumer Packaged Goods companies, Giant Biogene Holding Co ranks better than 77.58% on this metric.
The historical rank and industry rank for Giant Biogene Holding Co's Days Payable or its related term are showing as below:
HKSE:02367'
s Days Payable Range Over the Past 10 Years
Min: 39.81 Med: 53.06 Max: 80.51
Current: 80.51
During the past 7 years, Giant Biogene Holding Co's highest Days Payable was 80.51. The lowest was 39.81. And the median was 53.06.
HKSE:02367's Days Payable is ranked better than 77.58% of 1909
companies
in the Consumer Packaged Goods industry
Industry Median: 44.09
vs HKSE:02367: 80.51
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Giant Biogene Holding Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giant Biogene Holding Co Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Giant Biogene Holding Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Giant Biogene Holding Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co (HKSE:02367) has a Days Payable of 89.01 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Giant Biogene Holding Co and its competitors. This is 68% above median its historical median of 53.06. Over the past decade, Giant Biogene Holding Co's Days Payable has ranged from 39.81 to 80.51. According to the industry distribution chart, Giant Biogene Holding Co ranks #428 out of 1909 companies in the Consumer Packaged Goods industry, placing it in the top 22.4%.
Is Giant Biogene Holding Co's Days Payable too high?
Giant Biogene Holding Co's current Days Payable of 89.01 is 68% above median its 10-year median of 53.06. Over the past 10 years, this metric has ranged from a low of 39.81 to a high of 80.51. The Consumer Packaged Goods industry median Days Payable is 44.09. Giant Biogene Holding Co's value of 89.01 is 101.9% above this industry median. Based on the distribution chart, Giant Biogene Holding Co ranks #428 out of 1909 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Giant Biogene Holding Co ranks #428 out of 1909 companies for Days Payable. This places Giant Biogene Holding Co in the top 22% of its industry — outperforming the majority of peers. The industry median Days Payable is 44.09. Giant Biogene Holding Co's value of 89.01 is 101.9% above this benchmark. Historically, Giant Biogene Holding Co's own Days Payable has ranged from 39.81 to 80.51 over the past decade. While the company's 10-year median is 53.06 vs. the industry median of 44.09, Giant Biogene Holding Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.09, based on 1,909 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Giant Biogene Holding Co's current Days Payable of 89.01 is 101.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Giant Biogene Holding Co and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Giant Biogene Holding Co's current Days Payable is 89.01, which is 68% above median its own 10-year median of 53.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.00, compared to a current price of HK$24.28 — trading 64.3% below its estimated fair value. The current Days Payable is 89.01, which is 68% above median its 10-year median of 53.06 and 101.9% above the Consumer Packaged Goods industry median of 44.09. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Days Payable is 89.01 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?
Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued.
The current stock price of HK$24.28 is trading 64.3% below its estimated GF Value™ of HK$68.00.
GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.
Key valuation signals for HKSE:02367:
Days Payable: 89.01 (68% above median its 10-year median of 53.06)
GF Value™: HK$68.00 vs. price of HK$24.28 (64.3% below fair value)
Industry Position: 101.9% above the Consumer Packaged Goods median (#428 of 1909)
No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score
Get the complete analysis for HKSE:02367
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02367 has been successfully added to your 
